← Leaderboards
Steven B Harrod
University Of Kentucky
$1,300,177
Attributed
$1,300,177
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $252K · FY2007–11$500K$375K$250K$125K$0
'07
'08
'09
'10
'11
Funding mix
By agency
NIH$1,300,177 · 2
By mechanism
R01$1,227,565 · 1
F32$72,612 · 1
Top collaborators
No co-investigators on record.
Most similar at University Of Kentucky
Same institution · by research overlap
- Craig R Rush$27,535,139
- Linda P Dwoskin$22,762,643
- Sharon L. Walsh$101,480,172
- John A Stanford$3,858,416
- William Walton Stoops$15,269,484
Others in their field
Top investigators on “Tobacco”
- Gregory D Peterson · University Of Tennessee Knoxville$84,527,696
- Lloyd D Johnston · University Of Michigan At Ann Arbor$67,097,167
- Dorothy K Hatsukami · University Of Minnesota Twin Cities$55,710,357
- Richard A Miech · Johns Hopkins University$51,772,192
- Stephen T Higgins · University Of Vermont &St Agric College$45,191,145
- Stephen S Hecht · University Of Minnesota$41,546,048
Research focus
TobaccoMethamphetamineHyperactive BehaviorFosteringAdultBehavioralFemaleDrug Of AbuseAdolescenceFetal Tobacco ExposureBehaviorCigaretteCigarette SmokerCocaineBehavioral SensitizationEpidemiologic StudiesAdolescent SmokingExhibitsBody WeightDoseDrug AbuseChildChild BearingFemale Adolescents
Grant awards (7)
Prenatal IV nicotine: Long-term vulnerability to stimulant drugs$237,155
R01 · FY2011 · DA · contact PI
Prenatal IV nicotine: Long-term vulnerability to stimulant drugs$244,490
R01 · FY2010 · DA · contact PI
Prenatal IV nicotine: Long-term vulnerability to stimulant drugs$246,960
R01 · FY2009 · DA · contact PI
Prenatal IV nicotine: Long-term vulnerability to stimulant drugs$246,960
R01 · FY2008 · DA · contact PI
Prenatal IV nicotine: Long-term vulnerability to stimulant drugs$252,000
R01 · FY2007 · DA · contact PI
LOBELINE ANALOGS AND AMPHETAMINE SELF ADMINISTRATION$40,196
F32 · FY2001 · DA
LOBELINE ANALOGS AND AMPHETAMINE SELF ADMINISTRATION$32,416
F32 · FY2000 · DA